Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—implications for stopping rules and the HBV cure programme

Documents similaires

• Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply
  par: Chan Xie
  Publié: (2024)
• Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC
  par: Naohiro Yasuura, et autres
  Publié: (2024)
• Editorial: HBV Integration: A Possible Key Driver in the Course of Patients With Chronic HBV Infection Under Viral Suppression
  par: Hidenori Toyoda
  Publié: (2025)
• Editorial: HBV Integration—A Possible Key Driver on the Course of Patients With Chronic HBV Infection Under Viral Suppression. Authors' Reply
  par: Qin Ning, et autres
  Publié: (2025)
• Editorial: Beyond DNA Suppression: HBV RNA as a Predictor of Hepatocarcinogenesis
  par: Toshifumi Tada
  Publié: (2025)